ABH Healthcare Limited
Open now24–27 Aug 2026
Updated 2026-08-27 (IST)
What ABH Healthcare Limited does
ABH Healthcare Limited provides specialised tertiary medical care in Tier 3 cities within the state of Punjab, seeking to strike a balance between quality healthcare services and affordability. The company operates its hospital under the 'Anil Baghi Hospital' brand in Ferozepur, Punjab, with a capacity of 150 beds.
ABH Healthcare Limited financials
Rs crore · AnnualLatest year highlighted in green. Sparklines show the trend.
| 2024 | 2025 | 2026 | ||
|---|---|---|---|---|
| Sales | 41 | 49 | 53 | |
| Operating Profit | 7 | 13 | 15 | |
| OPM % | 16.7% | 26.8% | 28.0% | |
| Net Profit | 2 | 5 | 6 | |
| Total Debt | 36 | 42 | 55 |
ABH Healthcare Limited IPO offer structure
Fresh issue: ₹35 cr
The offer-for-sale component is not stated in what we extracted from the offer document, so the full issue size and the split between the two are unknown. This figure is the fresh issue alone, not the total raise. Fresh issue proceeds go to the company; OFS proceeds go to selling shareholders.
Issue size and split come from a public aggregator rather than the exchange, cross-checked against a second one. The offer document states the offer-for-sale as a share count against a blank amount, so it cannot be read from the document itself.
Use of proceeds- Repayment / prepayment, in part or full, of certain borrowings availed of by our Company: ₹17 cr
- Funding our working capital requirements: ₹5 cr
- Funding inorganic growth through unidentified acquisitions and general corporate purposes
ABH Healthcare Limited promoters and holding
- Dr. Kamal Baghi: Promoter and Whole-time Director
- Dr. Saurabh Baghi: Promoter and Managing Director
- Dr. Vaishali Saini: Promoter and Non-Executive Director
ABH Healthcare Limited strengths and risks
Company-stated strengths and disclosed risk factors from the offer document.
- Doctor led professional management team with proven execution capabilities. (p.129)
- Delivering quality clinical care by attracting and retaining experienced and renowned clinicians. (p.130)
- Diversified operations across clinical specialties, payor mix and hospitals. (p.130)
- Comprehensive operating infrastructure including information technology and modern equipments. (p.132)
- Track record of stable operating and financial performance and growth. (p.134)
- Our Company has been specifically formed for the purpose of acquisition of the business of M/s. Anil Baghi Hospital, thus we have limited operating history. (p.31)
- Our revenues are significantly dependent on our only hospital in Ferozepur, Punjab. (p.32)
- If we are unable to keep pace with technological changes, new equipments and service introductions, our business may be adversely affected. (p.32)
- We rely on certain third parties, including suppliers, and also enter into contracts with third-party payers. (p.33)
- We operate in a highly regulated industry, and compliance with applicable safety, health, environmental and other governmental regulations is required. (p.34)
ABH Healthcare Limited peer comparison: DRHP median P/E 26.1x
Live BSE prices| Company | CMP | P/E | OPM% | ROE% | Source |
|---|---|---|---|---|---|
| Sangani Hospitals Limited | — | 24.5x | — | — | DRHP |
| Maitreya Medicare Limited | — | -34.1x | — | — | DRHP |
| Asarfi Hospital Limited | Rs 214.95 -3.6% | 27.6x | — | — | live |
P/E from offer document where live data unavailable. Not a fair-value judgement.
ABH Healthcare Limited market and competition
Our extensive 35+ years of experience in the healthcare industry in the region where we operate has helped us develop a strong understanding of the region's market dynamics. In 2022, we were recognized as the leading hospital in Punjab among 720 hospitals empaneled with the State Health Agency, Punjab, and the National Health Authority.
ABH Healthcare Limited outlook, as the document states it
We plan to invest further in advanced medical technology to enhance our currently functioning departments and increase the range of services offered. We also plan to add two new specialties pertaining to oncology and Cardio-Thoracic & Vascular Surgery in the near future.
Never miss an IPO like this
Every upcoming IPO analysed: subscription, GMP and a DRHP breakdown, in your inbox, free. One email when each one opens.
ABH Healthcare Limited IPO: common questions
When does the ABH Healthcare Limited IPO open and close?
The ABH Healthcare Limited IPO is open from 24 Aug 2026 to 27 Aug 2026.
What is the lot size and minimum investment for the ABH Healthcare Limited IPO?
One lot is 1200 shares, and a retail application must be at least one lot. That is about ₹2,44,800 at the upper end of the band. An HNI application starts above Rs 2 lakh, so the minimum is higher for that category.
How much is the ABH Healthcare Limited IPO subscribed?
As of 27 Aug 2026 the total subscription is 1.04×.
When are the ABH Healthcare Limited IPO allotment and listing dates?
Not published yet. Derived from the close date on the usual timetable: allotment around 28 Aug 2026, refund/unblock around 31 Aug 2026 and listing around 1 Sep 2026. Treat these as estimates until the exchange confirms them.
How do I apply for the ABH Healthcare Limited IPO?
Through any broker app or your bank's net banking, using a demat account and a PAN. You bid in lots at a price inside the band, or at cut-off. The money is blocked in your account, not debited, until allotment. One application per PAN. We do not recommend brokers and carry no broker links. How to apply, start to finish →
Sources & method
Subscription and issue data come from the NSE and BSE exchange feeds, with the third-party aggregator, clearly labelled, where an exchange feed is unreachable. DRHP analysis is extracted from the offer document itself, every figure cited to its page. Each figure on the page carries its source and its timestamp.
Grey-market premium (GMP) is unregulated.
Every GMP figure is a self-reported grey-market estimate. No exchange, regulator or clearing body records or audits it, and there is no settlement guarantee or recourse. Shown for context only; never decide on GMP alone. New to GMP? The 30-second explainer → All live GMP, and its record →
How often do these actually open above the issue price?
Of the 563 SME IPOs that have listed on the NSE since 2021, 440 (78%) opened above their issue price, at a median of +14%. That is the segment's own record, not a forecast for this issue.